Vitamin A Kinetics and Mathematical Modeling in American Women

October 29, 2019 updated by: University of Wisconsin, Madison
Women were given a vitamin A tracer, and blood was sampled to determine individual and group vitamin A kinetics. Data were subsequently modeled using compartmental analysis to determine effects of study length on model outcomes.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This is a longitudinal study in which American women were given an oral, stable isotope tracer of vitamin A, and blood was sampled in a staggered, serial design to determine individual and group vitamin A kinetics. Data were subsequently modeled using compartmental analysis, and study truncation analysis was performed on data to investigate the factor of study duration on resulting vitamin A kinetic models and outputs related to vitamin A metabolism.

Study Type

Interventional

Enrollment (Actual)

8

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Wisconsin
      • Madison, Wisconsin, United States, 53706
        • Department of Nutritional Sciences, University of Wisconsin-Madison

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 30 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • BMI (18.5 - 24.9 kg/m2)

Exclusion Criteria:

  • Smoker
  • Pregnant
  • Trying to become pregnant
  • Lactating
  • Weight loss > 4.5 kg during the past 3 months.
  • Actively trying to lose weight
  • Inability to refrain from drinking alcohol when requested
  • Amenorrhea
  • Acute or chronic illness including hepatitis
  • Current or previous history of anorexia or bulimia
  • Concurrent participation in other studies
  • Family member already enrolled in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Vitamin A tracer
A stable isotope tracer of vitamin A was given orally.
A stable isotope tracer of vitamin A was given orally.
Other Names:
  • 13C vitamin A
  • 13C retinyl acetate

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total traced vitamin A mass
Time Frame: Baseline through 152 days
Total amount of endogenous vitamin A determined by mathematical model, (µmol).
Baseline through 152 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Compartmental model complexity
Time Frame: Baseline through 152 days
Required number of compartments in mathematical model needed to adequately fit data.
Baseline through 152 days
Compartmental model fractional transfer coefficients
Time Frame: Baseline through 152 days
Model parameters adjusted to fit analytical data. Represents the fractional transfer from one compartment to another in the model, (pools/d, represented as L(i,j), the fraction of compartment J transferred to compartment I per day).
Baseline through 152 days
Serum vitamin A half-life
Time Frame: Baseline through 152 days
Half-life of vitamin A in serum, (d).
Baseline through 152 days
Vitamin A disposal rate
Time Frame: Baseline through 152 days
Daily loss or utilization of vitamin A, (µmol/d).
Baseline through 152 days
Vitamin A equilibration time and partitioning
Time Frame: Baseline through 152 days
Time taken for vitamin A to equilibrate with body stores, (d).
Baseline through 152 days
Vitamin A tracer partitioning
Time Frame: Baseline through 152 days
Body partitioning of tracer between serum and extravascular compartment(s), relative to total tracee mass. Calculated as a ratio of tracer-to-tracee ratio (TTR) in serum and extravascular stores, (TTR serum / TTR stores).
Baseline through 152 days
Vitamin A dietary intake
Time Frame: Baseline
Vitamin A dietary intake by food frequency questionnaire, (µg retinol activity equivalents/d).
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sherry A Tanumihardjo, PhD, University of Wisconsin, Madison

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2008

Primary Completion (Actual)

September 1, 2008

Study Completion (Actual)

October 1, 2016

Study Registration Dates

First Submitted

August 8, 2017

First Submitted That Met QC Criteria

August 11, 2017

First Posted (Actual)

August 14, 2017

Study Record Updates

Last Update Posted (Actual)

October 31, 2019

Last Update Submitted That Met QC Criteria

October 29, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • H-2008-0020
  • A074600 (Other Identifier: UW Madison)
  • AG&LSC/NUTRITIONAL SCI/NUTRITI (Other Identifier: UW, Madison)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vitamin A Kinetics

Clinical Trials on Vitamin A tracer

3
Subscribe